Aptuit, a CRO focused on early to mid-phase drug development, has inked a deal with Chiesi Farmaceutici to develop new drugs for idiopathic pulmonary fibrosis.

Crown Bioscience will invest $1 million into establishment of a pharmaceutical R&D facility in Louisiana at New Iberia Research Center, one of the country’…

The European Medicines Agency recently held a workshop with stakeholders about adaptive pathways, which also allows more real-world data into drug approvals.

Charles River Laboratories has launched CRISPR/Cas9 services through a licensing deal with the Broad Institute, as a dispute over ownership of the technology…

Center Point Clinical Services is trying to translate digital tools' advantages of better communication and fewer costs into clinical research, as it…

A predictive model could help clinicians decide whether prostate cancer patients should be offered standard treatment or the chance to enter a clinical trial.

London-based trial services co Ergomed has penned a deal with Swedish biotech Asarina Pharma for its Phase IIb trial of sepranolone in patients with…

Cancer-related trials continued to account for the largest number of research studies done by CROs in any region of the world, says a new report.

PPD has expanded its GMP lab operations in Athlone, Ireland, by another 4,300 square feet to conduct analytical testing of biopharmaceuticals and inhalation…

R&D